These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Manchikanti L; Malla Y; Wargo BW; Fellows B Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372 [TBL] [Abstract][Full Text] [Related]
3. Utility of oral fluid in compliance monitoring of opioid medications. Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646 [TBL] [Abstract][Full Text] [Related]
4. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing. Matteliano D; Chang YP Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349 [TBL] [Abstract][Full Text] [Related]
6. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy. Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164 [TBL] [Abstract][Full Text] [Related]
7. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance. Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155 [TBL] [Abstract][Full Text] [Related]
8. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management. McCarberg BH Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461 [TBL] [Abstract][Full Text] [Related]
9. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test? Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816 [TBL] [Abstract][Full Text] [Related]
10. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain. Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612 [TBL] [Abstract][Full Text] [Related]
11. Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management. Boren LL; Locke AM; Friedman AS; Blackmore CC; Woolf R PM R; 2019 Nov; 11(11):1170-1177. PubMed ID: 30729723 [TBL] [Abstract][Full Text] [Related]
12. Role of urine toxicology testing in the management of chronic opioid therapy. Katz N; Fanciullo GJ Clin J Pain; 2002; 18(4 Suppl):S76-82. PubMed ID: 12479257 [TBL] [Abstract][Full Text] [Related]
14. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans. Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care. Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974 [TBL] [Abstract][Full Text] [Related]
17. Urine drug testing in chronic pain. Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368 [TBL] [Abstract][Full Text] [Related]
18. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic. Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305 [TBL] [Abstract][Full Text] [Related]